Benutzerspezifische Werkzeuge

Information zum Seitenaufbau und Sprungmarken fuer Screenreader-Benutzer: Ganz oben links auf jeder Seite befindet sich das Logo der JLU, verlinkt mit der Startseite. Neben dem Logo kann sich rechts daneben das Bannerbild anschließen. Rechts daneben kann sich ein weiteres Bild/Schriftzug befinden. Es folgt die Suche. Unterhalb dieser oberen Leiste schliesst sich die Hauptnavigation an. Unterhalb der Hauptnavigation befindet sich der Inhaltsbereich. Die Feinnavigation findet sich - sofern vorhanden - in der linken Spalte. In der rechten Spalte finden Sie ueblicherweise Kontaktdaten. Als Abschluss der Seite findet sich die Brotkrumennavigation und im Fussbereich Links zu Barrierefreiheit, Impressum, Hilfe und das Login fuer Redakteure. Barrierefreiheit JLU - Logo, Link zur Startseite der JLU-Gießen Direkt zur Navigation vertikale linke Navigationsleiste vor Sie sind hier Direkt zum Inhalt vor rechter Kolumne mit zusaetzlichen Informationen vor Suche vor Fußbereich mit Impressum

Titel

Artikelaktionen

Publikationen 2018

Wagenlehner FME, Pilatz A: Preventing urinary tract infections in patients with neurogenic bladder.

Lancet Infect Dis 18(9):926-927 (2018)

 

Wagenlehner FME, Diemer T: Re: Acute Pyelonephritis in Adults. Eur Urol 74(5):676. (2018)

 

Köves B, Cai T, Veeratterapillay R, Pickard R, Seisen T, Lam TB, Yuan CY, Bruyere F, Wagenlehner F, Bartoletti R, Geerlings SE, Pilatz A, Pradere B, Hofmann F, Bonkat G, Wullt B: Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur Urol 72:865-868 (2018)

 

Fijak M, Pilatz A, Hedger MP, Nicolas N, Bhushan S, Michel V, Tung KSK, Schuppe HC, Meinhardt A: Infectious, inflammatory and 'autoimmune' male factor infertility: how do rodent models inform clinical practice? Hum Reprod Update 24:416-441 (2018)

 

Maresch CC, Stute DC, Alves MG, Oliveira PF, de Kretser DM, Linn T. Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review. Hum Reprod Update 24:86-105 (2018) 

 

Kügler R, Mietens A, Seidensticker M, Tasch S, Wagenlehner FM, Kaschtanow A, Tjahjono Y, Tomczyk CU, Beyer D, Risbridger GP, Exintaris B, Ellem SJ, Middendorff R: Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects.FASEB J 32(3):1130-1138 (2018) 

 

Nesheim N, Ellem S, Dansranjavin T, Hagenkötter C, Berg E, Schambeck R, Schuppe HC, Pilatz A, Risbridger G, Weidner W, Wagenlehner F, Schagdarsurengin U: Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS. Oncotarget 13;9(28):19623-19639 (2018)

 

Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group: Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 121:101-110 (2018)

 

Wagenlehner F, Nowicki M, Bentley C, Lückermann M, Wohlert S, Fischer C, Vente A, Naber K, Dalhoff A: Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections. Antimicrob Agents Chemother 27;62(4) (2018)

 

Loose M, Naber KG, Shields P, Reinhart H, Wagenlehner FME: Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption. Int J Antimicrob Agents. 51:422-426 (2018)

 

Loose M, Naber KG, Hu Y, Coates A, Wagenlehner FME: Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1 positive colistin-resistant Escherichia coli. Int J Antimicrob Agents 52(6):783-789 (2018)

 

 

Wagenlehner FM, Abramov-Sommariva D, Höller M, Steindl H, Naber KG: Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute

Fritzenwanker M, Imirzalioglu C, Herold S, Wagenlehner FM, Zimmer KP, Chakraborty T: Treatment Options for Carbapenem-Resistant Gram-Negative Infections. Dtsch Arztebl 115(20-21):345-352. (2018)

 

Wagenlehner FM, Abramov-Sommariva D, Höller M, Steindl H, Naber KG: Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of acute lower uncomplicated urinary tract infections in women: A double-blind-parallel group, randomized, multicenter, non-inferiority phase III trial. Urol Int 101(3):327-336 (2018)

 

Fritzenwanker M, Imirzalioglu C, Herold S, Wagenlehner FM, Zimmer KP, Chakraborty T: Treatment Options for Carbapenem-Resistant Gram-Negative Infections. Dtsch Arztebl 115(20-21):345-352. (2018)

 

Roberts MJ, Scott S, Harris PN, Naber K, Wagenlehner FME, Doi SAR: Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol. 36:323-330 (2018)

 

Altinkilic B, Pilatz A, Diemer T, Wolf J, Bergmann M, Schönbrunn S, Ligges U, Schuppe HC, Weidner W: Prospective evaluation of scrotal ultrasound and intratesticular perfusion by color-coded duplex sonography (CCDS) in TESE patients with azoospermia. World J Urol 36(1):125-133 (2018)

 

Brobeil A, Wagenlehner F, Gattenlöhner S: Response to 'Aberrant expression of TdT in seminomatous germ cell neoplasia'. Virchows Arch 473(3):387 (2018) 

 

Brobeil A, Wagenlehner F, Gattenlöhner S: Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma: a potential diagnostic pitfall. Virchows Arch 472(3):433-440 (2018) 

 

Szarek M, Bergmann M, Konrad L, Schuppe HC, Kliesch S, Hedger MP, Loveland KL: Activin A target genes are differentially expressed between normal and neoplastic adult human testes: clues to gonocyte fate choice. Andrology 7:31-41 (2018) 

 

Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG: Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 18:107-117 (2018) 

Choe HS, Lee SJ, Cho YH, Çek M, Tandoğdu Z, Wagenlehner F, Bjerklund-Johansen TE, Naber K; GPIU Asian Investigators: Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother. 24:278-283 (2018)

 

Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M; MR2 study group: Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol.49:1311-1318 (2018) 

 

Balhorn R, Steger K, Bergmann M, Schuppe HC, Neuhauser S, Balhorn MC: New monoclonal antibodies specific for mammalian protamines P1 and P2. Syst Biol Reprod Med 64:424-447 (2018) 

 

 

Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM: The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part I: Urol Int. 100:263-270 (2018)

 

Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM: The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urol Int. 100:271-278 (2018)

 

Gierth M, Zeman F, Denzinger S, Vetterlein MW, Fisch M, Bastian PJ, Syring I, Ellinger J, Müller SC, Herrmann E, Gilfrich C, May M, Pycha A, Wagenlehner FM, Vallo S, Bartsch G, Haferkamp A, Grimm MO, Roigas J, Protzel C, Hakenberg OW, Fritsche HM, Burger M, Aziz A, Mayr R: Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study. Urol Int 101(1):16-24 (2018)

 

Wagenlehner FM, Abramov-Sommariva D, Höller M, Steindl H, Naber KG: Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial. Urol Int 19:1-10 (2018)

 

Pletz MW, Weis S, Forstner C, Wagenlehner F: Urosepsis. Med Klin Intensivmed Notfmed 113(2):143-156 (2018) 

 

Steger K, Balhorn R: Sperm nuclear protamines: A checkpoint to control sperm quality. Anat Histol Embryol 47:273-279 (2018)  

 

Naber KG, Kulchavenya E, Bichler KH, Wagenlehner FME: Urogenital tuberculosis and schistosomiasis (bilharzia) : Urological challenges in displaced persons]. Urologe 57(10):1191-1199 (2018)

 

Pletz MW, Weis S, Forstner C, Wagenlehner F: Urosepsis. Urologe 57(1): 79-92 (2018)

 

Hauptmann A, Wagenlehner FME, Diemer T: Current therapy of Peyronie's disease. Urologe 57(9):1139-1152 (2018)

 

Pletz MW, Weis S, Forstner C, Wagenlehner F: Urosepsis. Urologe 57:79-92 (2018)

 

Magyar A, Alidjanov J, Pilatz A, Nagy K, Arthanareeswaran VKA, Póth S, Bécsi A, Wagenlehner FME, Naber KG, Tenke P, Köves B: The role of the Acute Cystitis Symptom Score questionnaire for research and antimicrobial stewardship. Validation of the Hungarian version. Cent European J Urol. 71:134-141 (2018) 

 

Alidjanov JF, Naber KG, Abdufattaev UA, Pilatz A, Wagenlehner FME: Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part II. Patient-Reported Outcome Assessment. Antibiotics 7, 43 doi:103390/7020043 (2018) 

 

Cai T, Cocci A, Verze P, Rizzo M, Palmieri A, Liguori G, Trombetta C, Adembri C, Carini M, Bartoletti R, Wagenlehner FM, Bonkat G, Mirone V, Bjerklund Johansen TE, Novelli A: The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic? J Chemother 30:290-295 (2018)